Financial Statements for the year ended June 30, 2020 and the Management's Discussion and Analysis (MD&A) of Yong Thai Public Company Limited and its Subsidiaries. To Director and Manager, The Stock Exchange

Company Limited (the “Company”) and its subsidiaries hereby submit the Annual Financial Statements, ending December 31, 2019 and 2018, together with the clarification of the performance of the Company and

Syndicate Public Company Limited (the “Company”) and its subsidiaries hereby submit the Annual Financial Statements, ending December 31, 2018 and 2017, together with the clarification of the performance of

approved the reviewed financial statements, including the consolidated financial statements of the Company and its subsidiaries for the third quarter and nine month period ended 30th September 2020. The

regard, the company would like to report operating results for the second quarter of 2020 as follows Consolidated Financial Statements Ekachai Medical Care Public Company Limited and its subsidiaries

Director Ratio Analysis : Consolidated Financial Statements 1Q 1Q Unit : THB million 2019 2018 Returns (%) Return on Assets * 4.4% 3.1% Return on Equity * 5.6% 3.6% Working Capital Management (Days) Trade

Thailand The Meeting of the Board of Directors of KGI Securities (Thailand) Public Company Limited (“the Company”) No. 3/2020, held on 7th May 2020, has approved the reviewed financial statements including

คำอธิบายและการวิเคราะห์ฐานะการเงินและผลการดำเนินงาน * Note Please find further information in the consolidated financial statements. 1 February 21st, 2020 Subject: Management Discussion & Analysis

* Note Please find further information in the consolidated financial statements. 1 23 February, 2018 Subject: Management Discussion & Analysis (MD&A) for the year 2017 Attention: The President The

financial statements for the 3rd quarter of 2017 ending 30 September 2017, the Company would like to report factors that affect the financial performance for the 3rd quarter of 2017 as follows; Statements of